Combination of alpha2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder

Details for Australian Patent Application No. 2010320911 (hide)

Owner GALDERMA RESEARCH & DEVELOPMENT

Inventors Jomard, Andre; Delamadeleine, Francoise

Agent Griffith Hack

Pub. Number AU-A-2010320911

PCT Pub. Number WO2011/061252

Priority EP09176392.0 18.11.09 EP

Filing date 18 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 31/00 (2006.01)

A61K 31/196 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/061252 Priority application(s): WO2011/061252

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010320918-Treatment of cancer or tumor induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternative magnetic field

2010320885-Syringe